The pharmaceutical Vivus Inc. is working on a new drug, avanafilo to treat erectile dysfunction, which could yield results within 30 minutes or less (including 15 minutes), exceeding the time required for Viagra.
The drug, whose trade name is still unknown and is still in clinical trials, has been tested successfully by more than 646 patients.
From Vivus Inc., Leland Wilson, executive director of the company, says that patients "frequently change medicine," says Wilson, "because they are dissatisfied with the results." And is that the rate at getting results is valued by patients over other aspects.
This new drug also promises to reduce side effects during clinical trials because they were reduced to mild headaches and dizziness.